Vaginal versus sublingual misoprostol for second-trimester pregnancy termination and effect on Doppler measurements.
OBJECTIVE
To compare the efficacy of vaginal versus sublingual misoprostol for second-trimester pregnancy termination, and to evaluate the effect on the blood flow of the uterine and umbilical arteries.


METHODS
Forty-nine patients were randomized to receive either 200 microg of vaginal misoprostol every 6 hours or 200 microg of misoprostol sublingually every 6 hours. Doppler velocimetry studies were assessed immediately before and 60 minutes after the administration of the first dose. Standard descriptive calculations, Mann-Whitney U, Wilcoxon, and chi(2) tests were performed.


RESULTS
The mean interval between induction and onset of active labor, induction and delivery, and the duration of oxytocin administration were significantly shorter in the sublingual misoprostol group. Both routes of administration increased the Doppler indices for the uterine arteries; however, misoprostol via the sublingual route did not affect the umbilical arteries.


CONCLUSIONS
Sublingual administration of misoprostol for second-trimester medical abortion results in a higher success rate and does not affect umbilical blood flow.
Karsidag
A Yasemin Karageyim
AY
Obstetrics Department, Dr Lutfi Kirdar Kartal Education and Research Hospital, Kartal, Istanbul, Turkey. ykarageyim@yahoo.com
Buyukbayrak
Esra E
EE
Kars
Bulent
B
Dansuk
Ramazan
R
Unal
Orhan
O
Turan
M Cem
MC
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D000286:Administration, Sublingual; D001783:Blood Flow Velocity / Q000187:drug effects; D005260:Female; D006801:Humans; D017078:Laser-Doppler Flowmetry; D016595:Misoprostol / Q000008:administration & dosage; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D012039:Regional Blood Flow / Q000187:drug effects; D016896:Treatment Outcome; D014463:Ultrasonography; D014469:Umbilical Arteries / Q000000981:diagnostic imaging / Q000187:drug effects*; D014599:Uterus / Q000098:blood supply*
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol